Back to BBIO

ADAR1 Capital Management, LLC → BBIO

ADAR1 Capital Management, LLC BBIO Position History

BridgeBio Pharma, Inc. • Healthcare

Quarters held
11
Latest value
$4.5M
Q3 2026
Peak value
$25M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$16.3M
Q4 2025$16.3M
Q1 2026$7M
Q1 2026$3.6M
Q1 2026$4.9M
Q2 2026$13.2M
Q2 2026$3.5M
Q2 2026$5M
Q3 2026$25M
Q3 2026$3.1M
Q3 2026$4.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$4.5M30.0K——
Q3 2026$3.1M20.0K——
Q3 2026$25M379.3K——
Q2 2026$5M30.0K——
Q2 2026$3.5M20.0K——
Q2 2026$13.2M176.7K——
Q1 2026$4.9M30.0K——
Q1 2026$3.6M20.0K——
Q1 2026$7M94.3K——
Q4 2025$16.3M213.4K——
Q4 2025$16.3M213.4K——

Other funds holding BBIO

Other ADAR1 Capital Management, LLC positions

AAVXF

ABIVAX SA

$240.5M
AAVXF

ABIVAX SA

$203.1M
AAVXF

ABIVAX SA

$177.6M
AAVXF

ABIVAX SA

$177.6M
AAVXF

ABIVAX SA

$155.2M
SPY

STATE STR SPDR S&P 500 ETF T

$135.5M
PB

PROTAGONIST THERAPEUTICS INC

$134M
PB

PROTAGONIST THERAPEUTICS INC

$117.8M